Conjupri

Active Ingredient(s): Levamlodipine
FDA Approved: * December 19, 2019
Pharm Company: * CSPC OUYI PHARMA CO LTD
Category: Blood Pressure

Levamlodipine (INN), also known as levoamlodipine or S-amlodipine is a pharmacologically active enantiomer of amlodipine.[1] Amlodipine belongs to the dihydropyridine group of calcium channel blocker used as an antihypertensive and antianginal agent.[2] Levamlodipine is currently marketed in Russia under the brand name EsCordi Cor (Actavis Pharma), in Brazil under the brand name Novanlo (Biolab Sanus) and in India under the trade names Eslo (Zuventus Healthcar... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Conjupri 1.25 mg/1.25mg Oral Tablet
NDC: 24075-0410
Labeler:
Cspc Ouyi Pharmaceutical Co. Ltd
Conjupri 2.5 mg/2.5mg Oral Tablet
NDC: 24075-0411
Labeler:
Cspc Ouyi Pharmaceutical Co. Ltd
Conjupri 5 mg/5mg Oral Tablet
NDC: 24075-0412
Labeler:
Cspc Ouyi Pharmaceutical Co. Ltd
Conjupri 5 mg/5mg Oral Tablet
NDC: 24075-0413
Labeler:
Cspc Ouyi Pharmaceutical Co. Ltd
Conjupri 2.5 mg Oral Tablet
NDC: 66992-425
Labeler:
Wraser LLC
Conjupri 5 mg Oral Tablet
NDC: 66992-430
Labeler:
Wraser LLC
Conjupri 1.25 mg Oral Tablet
NDC: 69101-512
Labeler:
Burke Therapeutics, LLC
Conjupri 2.5 mg Oral Tablet
NDC: 69101-525
Labeler:
Burke Therapeutics, LLC
Conjupri 5 mg Oral Tablet
NDC: 69101-550
Labeler:
Burke Therapeutics, LLC